364 filings
Page 2 of 19
8-K
cu1gbv a6cu5z
14 Sep 22
BioCryst Names Dr. Bill Sheridan Chief Development Officer and Appoints Dr. Ryan Arnold Chief Medical Officer
4:08pm
8-K
ktydq0viqdo9ci8 81v
25 Aug 22
Regulation FD Disclosure
7:03am
8-K
5yhuhvjc3 ocla
4 Aug 22
BioCryst Reports Second Quarter 2022 Financial Results and Upcoming Key Milestones
7:06am
8-K
ll4kirui
7 Jun 22
Departure of Directors or Certain Officers
4:53pm
8-K
hpwkgv
5 May 22
BioCryst Reports First Quarter 2022 Financial Results and Upcoming Key Milestones
7:05am
8-K
8dc10bwj0rb5k4cp4v
11 Apr 22
Regulation FD Disclosure
8:01am
8-K
tfv2ukk31mg278f1agt2
8 Apr 22
Other Events
9:17am
8-K
eszwc3zl eh
23 Feb 22
BioCryst Reports Fourth Quarter and Full Year 2021 Financial Results and Upcoming Key Milestones
7:02am
8-K
m2aig7nbk3r4q0yo4s
22 Feb 22
BioCryst Begins Patient Enrollment in RENEW Proof-of-Concept Trial Evaluating BCX9930 for Patients with Renal Complement-mediated Diseases
7:03am
8-K
dvj8m
17 Feb 22
Regulation FD Disclosure
4:05pm
8-K
edijmwudq wtbyb8
8 Feb 22
BioCryst Appoints Machelle Sanders to Board of Directors
7:06am
8-K
7xbm7w1uxsyi8uu vr
10 Jan 22
Results of Operations and Financial Condition
7:04am
8-K
stabd7a1g8npw btr
7 Jan 22
BioCryst Begins Patient Enrollment in REDEEM-1 Pivotal Trial Evaluating BCX9930 as Oral Monotherapy for Patients with PNH
9:34am
8-K
x6b3s246wa98og8rrb
29 Nov 21
BioCryst Begins Patient Enrollment in REDEEM-2 Pivotal Trial Evaluating BCX9930 as Oral Monotherapy for Patients with PNH
8:33am
8-K
quht kfqvkl1bbyikav
22 Nov 21
Entry into a Material Definitive Agreement
7:03am
8-K
vsk 3ngv2eqpjq
3 Nov 21
BioCryst Reports Third Quarter 2021 Financial Results and Upcoming Key Milestones
7:04am
8-K
lfhb5n
20 Sep 21
BioCryst Appoints Dr. Amy McKee to Board of Directors
7:06am
8-K
c811jiyi
1 Sep 21
U.S. Government Exercises Option to Purchase Additional RAPIVABĀ® (peramivir injection) from BioCryst for Delivery to Strategic National Stockpile
7:04am
8-K
o5uh3hrmst75xw8pm6r
26 Aug 21
BioCryst Appoints Dr. Steven Galson to Board of Directors
7:05am
8-K
ftx 1v92u0xg2q
9 Aug 21
Departure of Directors or Certain Officers
7:23am